Pure Global

TheraPAP Equivalence Crossover Study - Trial NCT06238362

Access comprehensive clinical trial information for NCT06238362 through Pure Global AI's free database. This phase not specified trial is sponsored by SleepRes Inc. and is currently Recruiting. The study focuses on Obstructive Sleep Apnea. Target enrollment is 150 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06238362
Recruiting
other
Trial Details
ClinicalTrials.gov • NCT06238362
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
TheraPAP Equivalence Crossover Study
Randomized Crossover Study to Compare Effectiveness of a Device Providing Pressure Drops During Inspiration (TPAP) to Continuous Positive Airway Pressure (CPAP) in Obstructive Sleep Apnea (OSA)

Study Focus

Obstructive Sleep Apnea

TPAP

Interventional

other

Sponsor & Location

SleepRes Inc.

Clarksville, United States of America

Timeline & Enrollment

N/A

Mar 07, 2024

Jul 30, 2024

150 participants

Primary Outcome

Apnea/Hypopnea Index

Summary

The present study, TheraEquivalence, is a Phase 2 crossover study designed to examine the
 efficacy and safety of TheraPAP (TPAP) vs. CPAP alone in the treatment of OSA.

ICD-10 Classifications

Sleep apnoea
Sleep disorders
Sleep disorder, unspecified
Primary sleep apnoea of newborn
Nonorganic sleep disorders

Data Source

ClinicalTrials.gov

NCT06238362

Non-Device Trial